-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Axogen, Raises Price Target to $60

Benzinga·10/29/2026 14:38:05
Truist Securities analyst Ravi Misra maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $53 to $60.